RETRACTED: Tetramethylpyrazine alleviates lipopolysaccharide-induced damage in ATDC5 cells via down-regulating MyD88

Qiang Li, Wanying Xing, Xiong Xu, Sulong Wang, Yisha He, Yueshu Wang, Hongbin Sun

Open source

DOI
10.1016/j.yexmp.2019.104317
Published
2019-12
Container
Experimental and Molecular Pathology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yexmp.2019.104317,
  title = {RETRACTED: Tetramethylpyrazine alleviates lipopolysaccharide-induced damage in ATDC5 cells via down-regulating MyD88},
  author = {Qiang Li and Wanying Xing and Xiong Xu and Sulong Wang and Yisha He and Yueshu Wang and Hongbin Sun},
  year = {2019},
  journal = {Experimental and Molecular Pathology},
  doi = {10.1016/j.yexmp.2019.104317},
  url = {https://doi.org/10.1016/j.yexmp.2019.104317}
}

RIS

TY  - JOUR
TI  - RETRACTED: Tetramethylpyrazine alleviates lipopolysaccharide-induced damage in ATDC5 cells via down-regulating MyD88
AU  - Qiang Li
AU  - Wanying Xing
AU  - Xiong Xu
AU  - Sulong Wang
AU  - Yisha He
AU  - Yueshu Wang
AU  - Hongbin Sun
PY  - 2019
JO  - Experimental and Molecular Pathology
DO  - 10.1016/j.yexmp.2019.104317
UR  - https://doi.org/10.1016/j.yexmp.2019.104317
ER  - 

APA

Li, Q., Xing, W., Xu, X., Wang, S., He, Y., Wang, Y., & Sun, H. (2019). RETRACTED: Tetramethylpyrazine alleviates lipopolysaccharide-induced damage in ATDC5 cells via down-regulating MyD88. Experimental and Molecular Pathology. https://doi.org/10.1016/j.yexmp.2019.104317

Source records